Progesterone reduces immobility in rats forced to swim

Archives of Medical Research

Volumn 30, Issue 4, 1999, Pages 286-289

  Martínez Mota, Lucía ^a   Contreras, Carlos M ^a,b,c   Saavedra, Margarita ^a  

^a UNIVERSIDAD VERACRUZANA   (Mexico)

^b UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^c NONE   (Mexico)

Author keywords

Antidepressants; Depression; Forced swim test; Progesterone; Rat

Indexed keywords

PROGESTERONE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DEPRESSION; DRUG ACTIVITY; DRUG EFFECT; DRUG SCREENING; FORCED SWIMMING TEST; IMMOBILIZATION; LOCOMOTION; NONHUMAN; OVARIECTOMY; RAT;

EID: 0033167041     PISSN: 01880128     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0188-0128(99)00024-x     Document Type: Article

References (39)

1. Jiang N., Chopp M., Stein D., Feit H. Progesterone is neuroprotective after transient middle cerebral artery occlusion in male rats. Brain Res. 735:1996;101.
2. Jung Testas I., Schumacher M., Robel P., Baulieu E.E. The neurosteroid progesterone increases the expression of myelin proteins (MBP and CNPase) in rat oligodendrocytes in primary culture. Cell Mol Neurobiol. 16:1996;439.
3. Kokate T.G., Banks M.K., Magee T., Yamaguchi S.I., Rogawski M.A. Finasteride, a 5-alfa-reductase inhibitor, blocks the anticonvulsant activity of progesterone in mice. J Pharmacol Exp Ther. 288:1998;679.
4. Kokate T.G., Svensson B.E., Rogawski M.A. Anticonvulsant activity of neurosteroid. correlation with gamma-aminobutyric acid-evoked chloride current potentiation J Pharmacol Exp Ther. 270:1994;1233.
5. Litter B.C., Matta R.J., Zahn T.P. Physiological and psychological effects of progesterone in men. J Nerv Ment Dis. 159:1974;256.
6. Pearlstein T.B. Hormones and depression. what are the facts about premenstrual syndrome, menopause, and hormone replacement therapy? Am J Obstet Gynecol. 173:1995;646.
7. Kroboth P.D., McAuley J.W. Progesterone. does it affect response to drug? Psychopharmacol Bull. 33:1997;297.
8. Rodríguez-Sierra J.F., Howard J.L., Pollard G.T., Hendriks S.E. Effect of ovarian hormones on conflict behavior. Psychoneuroendocrinology. 9:1984;293.
9. Fernández-Guasti A., Picazo O. Changes in burying behavior during the estrous cycle. effect of estrogen and progesterone Psychoneuroendocrinology. 17:1992;681.
10. Picazo O., Fernández-Guasti A. Changes in experimental anxiety during pregnancy and lactation. Physiol Behav. 54:1993;295.
11. Bitran D., Dowd J.A. Ovarian steroids modify the behavioral and neurochemical responses of the central benzodiazepine receptor. Psychopharmacology (Berlin). 125:1996;65.
12. De Angelis L. Experimental anxiety and antidepressant drugs. the effects of meclobemide, a selective MAO-A inhibitor, fluoxetine and imipramine in mice Nauyn-Schmiedebergs Arch Pharmacol. 354:1996;379.
13. Schreiber R., De Vry J. 5-HT1A receptor ligands in animal models of anxiety, impulsivity and depression. multiple mechanisms of action? Prog Neuropsychopharmacol Biol Psychiatry. 17:1993;87.
14. Tyrer P., Tyrer J. Antidepressive drugs for treatment of anxiety disorders - and vice versa. Den Boer J.A., Sitsen J.M. Handbook of Depression and Anxiety. A Biological Approach. 1994;Marcel Dekker, New York. 497.p.
15. Bernardi M., Vergoni A.V., Sandrini M., Tagliavini S., Bertolini A. Influence of ovariectomy, estradiol and progesterone on the behavior of mice in an experimental model of depression. Physiol Behav. 45:1989;1067.
16. Borsini F., Meli A. Is the forced swimming test a suitable model for revealing antidepressant activity? Psychopharmacology. 94:1988;147.
17. Borsini F., Lecci A., Sessarego A., Frassine R., Meli A. Discovery of antidepressant activity by forced swimming test may depend on pre-exposure of rats to a stressful situation. Psychopharmacology. 97:1989;183.
18. Borsini F. Role of serotonergic system in the forced swimming test. Neurosci Biobehav Rev. 19:1995;377.
19. Danysz W., Plaznik A., Kostowski W., Jarbe T.U.C., Hiltuen A.J., Archer T. Comparison of desipramine, amitriptyline, zimelidine and alaprociate in six animal models used to investigate antidepressant drugs. Pharmacol Toxicol. 62:1988;42.
20. Porsolt R.D., Pichon M.L., Jalfre M. Depression. a new animal model sensitive to antidepressant treatments Nature. 266:1977;730.
21. Porsolt R.D., Lenègre A. Behavioral models of depression. Elliot J.M., Heal D.J., Maisden C.A. Experimental Approaches to Anxiety and Depression. 1992;John Wiley & Sons, New York. 73.p.
22. West A.P. Neurobehavioral studies of forced swimming. the role of learning and memory in the forced swim test Prog Neuropsychopharmacol Biol Psychiatry. 14:1990;863.
23. Willner P. Sensitization to the actions of antidepressants drugs. Goudie A.J., Emmete-Oglesby M. Psychoactive Drugs. 1989;The Humana Press, Totowa, NJ. 407.p.
24. A receptor function. TIPS. 16:1995;285.
25. Mahesh V.B., Brann D.W., Hendry L.B. Diverse modes of action of progesterone and metabolites. J Steroid Biochem Mol Biol. 56:1996;1.
26. Geary N., Trace D., McEwen B., Smith G.P. Cyclic estradiol replacement increases the satiety effect of CCK-8 in ovariectomized rats. Physiol Behav. 56:1994;281.
27. Albert D.J., Jonik R.H., Walsh M.L. Interaction of estradiol, testosterone, and progesterone in the modulation of hormone-dependent aggression in the female rat. Physiol Behav. 52:1992;773.
28. Garguilo P.A., Muñoz V., Donoso A.O. Inhibition by N-methyl-D-aspartic acid (NMDA) receptor antagonist of lordosis behavior induced by estrogen followed by progesterone or luteinizing-releasing hormone (LHRH) in the rat. Physiol Behav. 52:1992;737.
29. McEwen B.S. Non-genomic and genomic effects of steroids on neural activity. TIPS Rev. 12:1991;141.
30. A receptor mechanism of action and physiological significance Prog Neurobiol. 38:1992;379.
31. Brann D.W., Hendry L.B., Mahesh V.B. Emerging diversities in the mechanism of action of steroid hormones. J Steroid Mol Biol. 2:1995;113.
32. Majewska M.D., Harrison N.L., Schwartz R.D., Barker J.L., Paul S.M. Steroid hormone metabolites are barbiturate-like modulators of the GABA receptor. Science. 232:1986;1004.
33. A-benzodiazepine receptor. Eur J Pharmacol. 188:1990;401.
34. A receptor and central-type and peripheral-type benzodiazepine receptors. Brain Res. 752:1997;307.
35. Smith S.S., Waterhouse B.D., Chapin J.K., Woodward D.J. Progesterone alters GABA and glutamate responsiveness. a possible mechanism for its anxiolytic action Brain Res. 400:1987;353.
36. Fernández-Teruel A., Boix F., Escorihuela R.M., Yáñez P., Tobeña A. Sodium valproate reduces immobility in the behavioral "despair" test in rats. Eur J Pharmacol. 152:1988;1.
37. Fernández-Teruel A., Boix F., Escorihuela R.M., Guix T., Tobeña A. Activity of several GABAergic agents on the behavioral "despair" test in rats. Psychiatr Psychobiol. 4:1989;167.
38. Sluzewska A., Nowakowska E., Stachowiak I. Antidepressant-like effects of carbamazepine. the role of GABAergic agents Pharmacol Res. 25(S2):1992;65.
39. Semba J., Kuroda Y., Takahashi R. Potential antidepressant properties of subchronic GABA transaminase inhibitors in the forced swimming test in mice. Neuropsychobiology. 21:1989;152.